Phase I-IIa trials

- bioequivalence and bioavailability studies

- first in man and dose escalation studies

- drug-drug interaction and food-drug interaction studies

- studies in special populations

- studies using special methods like endoscopy

- patient recruitment in various indications


Performance of studies is supported by significant in-depth experience gained over many years, assuring low variability and reliable results.